Levels of enzymatic lactate dehydrogenase activity in patients suffering from oral cancer
Keywords:
DeCS, MOUTH CANCER, BIOMARKERSAbstract
Introduction: in recent years the prevalence of oral cancer has increased, making it necessary to look for tests to establish the early risks of suffering from this disease. There are different cellular and tissue biomarkers that from a molecular perspective provide additional information apart from the clinical examination.
Objective: to determine the levels of enzymatic activity of lactate dehydrogenase [LDH] in patients with oral cancer, Pinar del Río 2015-2016.
Method: an observational, descriptive and cross-sectional study was carried out in a sample of 60 patients who attended for first time at the consultation of head and neck cancer, III Congreso Cancer Hospital in Pinar del Río, from September 2015 to June 2016. A survey was applied and the data were collected from the clinical histories, determining the levels of enzymatic lactate dehydrogenase activity.
Results: 82% of patients were male; the age bracket was 60 years and older, the most representative group (70%); degree-I carcinoma (50%); stage-IV carcinoma (53%) was the most frequent found; 55% showed elevated levels of lactate dehydrogenase.
Conclusions: male patients 60 years and older were the most affected by oral cancer. Degree I and stage IV carcinomas resulted in the most frequent lesions. There was a close relationship between the degree and stage of carcinomas and the elevated levels of lactate dehydrogenase in patients included on the study.
DeCS: MOUTH CANCER; BIOMARKERS
Downloads
References
1. Madera Anaya M.V. Salivary analysis of oral cancer biomarkers. Av Odontoestomatol [revista en la Internet]. 2013 Dic [citado 2015 Dic 16]; 29(6): 293-302. Disponible en:
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-12852013000600003&lng=es.
2. Colectivo de Autores. Programa de detección del cáncer bucal. (PDCB). [Internet]. La Habana: Editorial Ministerio de Salud Pública; Octubre 2001. [Citado 11 Mar 2016]; Disponible en: http://www.sld.cu/galerias/doc/sitios/cirugiamaxilo/programa_de_deteccion_del_cancer_bucal.doc
3. Rodríguez N, Álvarez Blanco Y, Cárdenas Pérez E, Cruz Betancourt MC, Morales Pardo MI, Cepero Franco F. Caracterización de las remisiones del Programa de Detección Precoz del cáncer bucal al segundo nivel de atención en el área norte de Ciego de Ávila. MEDICIEGO [Internet]. 2012 [citado 2016 Mar 19]; 18(Supl.1): [Aprox. 26 p.]. Disponible en: http://www.bvs.sld.cu/revistas/mciego/vol18_supl1_2012/pdf/T13.pdf
4. Portelles Massó AM. El cáncer oral como problema de salud. Correo Científico Médico [Internet]. 2012 [citado 2016 Mar 13]; 16(1): [Aprox. 6 p.]. Disponible en: http://revcocmed.sld.cu/index.php/cocmed/article/view/81/21
5. MINSAP. Anuario Estadístico de Salud 2012. [Internet]. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud; 2013. [citado 2016 May 29]; [Aprox. 2 p.]. Disponible en: http://files.sld.cu/dne/files/2013/04/anuario_2012.pdf
6. González Crespo E. Comportamiento del cáncer bucal en la provincia Pinar del río. 2005. [tesis]. Pinar del Río: Universidad de Ciencias Médicas Ernesto Guevara. Filial Provincial de Estomatología; 2005.
7. Rodríguez R E, Santana Fernández K A, Fong González Y, Rey Ferrales Y, Jacas Gómez M J, Quevedo Peillón K. Evaluación del programa de detección precoz del cáncer bucal. AMC [Internet]. 2014 Dic [citado 2016 Ago 26]; 18(6): 642-655. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S102502552014000600007&lng=es.
8. Gaitan-Cepeda LA, Peniche-Becerra AG, Quezada-Rivera D. Trends in frequency and prevalence of oral cancer and oral squamous cell carcinoma in Mexicans. A 20 years retrospective study. Med Oral Patol Oral Cir Bucal 2011; 16(1):e1-5.
9. González Ramos RM, Herrera López IB, Osorio Núñez M, Madrazo Ordaz D. Principales lesiones bucales y factores de riesgo presentes en población mayor de 60. Rev. Cubana Estomatología [Internet]. 2010 Mar [citado 2016 Mar 13]; 47(1): [Aprox. 18 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75072010000100009&lng=es
10. Miranda Tarragó JD, Fernández Ramírez L, García Heredia GL, Rodríguez Pérez I, Trujillo Miranda E. Pacientes remitidos por el Programa de Detección de Cáncer Bucal. Facultad de Estomatología de La Habana. 1999-2006. Rev. Cubana Estomatol [Internet]. 2010 oct.-dic. [citado 2016 Mar 13]; 47(4): [Aprox. 8 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75072010000400001
11. Rivera C. Opportunities for biomarkers with potential clinical use in the detection of oral cancer. Medwave 2015 Jul;15(6):e6182 doi: 10.5867/medwave.2015.06.6186
12. Duffy MJ, Sturgeon CM, Soletormos G, Barak V, Molina R, Hayes DF, et al. Validation of New Cancer Biomarkers: A Position Statement from the European Group on Tumor Markers. Clin Chem. 2015 Jun; 61(6):809-820. | PubMed |
13. Bórquez P, Capdeville F, Madrid A, Veloso M, Cárcamo M. Sobrevida global y por estadios de 137 pacientes con cáncer intraoral: Experiencia del Instituto Nacional del Cáncer. Rev. Chil Cir [Internet]. 2011 Ago [citado 2016 Mar 13]; 63(4): [Aprox. 8 p.]. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-40262011000400003&lng=es
14. O'Sullivan B, Shah J. New TNM staging criteria for head and neck tumors. Semin. Surg. Oncol. 21:30-42, 2003. © 2003 Wiley-Liss, Inc. Consultado 10 Mar 2016. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/ssu.10019/abstract
15. Fariñas L. Cuba: el reto de enfrentar el cáncer. Congreso de Oncología, Habana 2014, XI. 2014 Nov 19. Disponible en:
http://www.cubahora.cu/ciencia-y-tecnologia/cuba-el-reto-de-enfrentar-el-cancer
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
